GDGustavo de Carvalho Duarte

Gustavo de Carvalho Duarte

*This is an algorithmically generated author record based on publicly available information.

Gustavo de Carvalho Duarte has a total of 51 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Monitoring and feedback using data in transfusion medicine: A study of practices from the BEST Collaborative

    by Ryan A. Metcalf, Allison Mo, Sandra K. White, Gustavo C. Duarte, Nancy M. Dunbar, Katie Hands, Anil K. Panigrahi, Jessica L. Poisson, Nabiha H. Saifee, Hua Shan, et al.

    Background: It is imperative that health systems monitor transfusion practice quality and implement improvements when evidence‐based practice gaps are identified. Despite the importance of data‐driven quality activities, little is known about approaches employed by hospitals. This study aimed to describe strategies used by hospitals to acquire, analyze, and apply transfusion‐related quality data. Study Design and Methods: A pre‐piloted survey was developed by the core team, and Biomedical Excellence for Safer Transfusion (BEST) Collaborative attendees of meetings were invited to participate. Topics spanned five domains: hospital characteristics, data acquisition, quality metric prioritization, data analysis/visualization, and feedback processes. Responses were summarized to identify patterns and variation across institutions. Results: Nine hospitals of varying size, specialty mix, and transfusion volumes from three continents participated. Most transfusion services acquired transfusion data from both the electronic health record and the laboratory information system (6/9, 67%). Although all sites tracked the number of transfusions, there was wide variation in other metrics prioritized. Transfusion appropriateness was prioritized by 7 of 9 centers, but few reported monitoring antifibrinolytic agent use (2/9, 22%), anemia management (4/9, 44%), and consent (2/9, 22%). All hospitals performed some form of data analysis, but chart/table types and functionalities differed. Feedback was typically provided by transfusion medicine specialists or hematology, but frequency and means differed between sites. Discussion: This descriptive study highlights significant variation in how selected hospitals use data to monitor transfusion practices and provide feedback. There are many opportunities to enhance optimal uses of data to deliver effective quality improvement.

  • Open Access

    Post-thaw CD34+ cell recovery likely degraded under extreme graft platelet concentrations

    by Gustavo C. Duarte, Leandro Ladvanszky, Gavin Atkinson, Michelle Burns, Dona Madola, Deepak Sadani, Marcus Yan-Fischer, Hemant Patel, Jacynthe Tremblay, Andrew Butler, et al.

    Impaired post-thaw CD34 cell (postCD34) viability in autologous haematopoietic stem cell transplant (ASCT) could indicate delayed engraftment where multiple factors might complicate the relationship. Despite of a couple of unconfirmed reports of a negative correlation of platelet concentration with postCD34 viability, how platelets might be involved in the relationship is largely unknown. Therefore, this question was addressed in this retrospective study of 82 ASCT patients with a total of 150 collections of peripheral blood stem cells in New Zealand. A significant negative correction between platelet concentration and postCD34 recovery (r = −0.18, p = 0.028) was observed overall, but upon further analysis only confirmed in the subset with graft platelets 1500–2000 ×109/L. Importantly, the postCD34 recovery was clearly reduced in the subgroups with either the lowest or the highest platelet concentration. The lowest subgroup was enriched with collections from patients with Hodgkin or non-Hodgkin lymphoma, whereas the highest subgroup from patients with multiple myeloma, both with clearly male preponderance. We hypothesized that graft platelet concentrations probably indicated CD34 cell state (e.g. cell cycle and cell adhesion highly related to platelet functions) that sustained when platelet concentrations were within a niche range but went out of kilter otherwise.

  • Open Access

    A patient blood management perspective on Anemia in the obese patient journey

    by Gustavo de Carvalho Duarte, Wenhua Wei, Gavin Cho

    Obesity and anemia are increasing prevalence around the globe. They can interplay and are both associated with high morbidity and poorer clinical outcomes. Inflammation and iron deficiency are important contributors to anemia in obese patients. Furthermore, obesity surgery can trigger high blood loss, increased demand for blood transfusions and long-term nutrient deficiency. Patient blood management programs have been crucial in improving patients' clinical results whilst minimizing costs in many different settings, such as orthopedic surgery, cardiovascular surgery, pregnancy and intensive care unit patients. In this mini-review, we will discuss applications of patient blood management principles in caring of obese individuals during the patient journey.


  • Open Access

    A critical assessment of dose effects of post‐thaw CD34 on autologous stem cell transplantation treatment of haematological malignancies

    by Gustavo de Carvalho Duarte, Andrew Butler, Gavin Atkinson, Krishna Badami, Wen‐Hua Wei

    A consensus threshold of pre-cryopreservation CD34-positive cells (CD34s) has been used as the minimum dose to initiate autologous stem cell transplantation (ASCT). Advances in cryopreservation posed a debate whether post-thaw CD34s might be a superior surrogate instead. We addressed the debate in this retrospective study of 217 adult ASCTs in five different haematological malignancies treated at a single centre. We showed that post-thaw CD34s was highly correlated with pre-cryopreservation CD34s (r = 0.97) and explained similar to 2.2% (p = 0.003) of the variation of the post-thaw total nucleated cell viability that however had no power to predict engraftment outcomes. After stratifying the ASCT cases into four dose groups based on post-thaw CD34s reinfused, stepwise multivariate regression analyses detected significant effects in dose group and interactions with diseases for neutrophil and platelet recovery respectively. The significant dose effects and interactions were triggered by two technical outliers in the low dose group, and disappeared in the repeated regressions after exclusion of the outliers where disease and age were the significant predictors remained. Our data clearly support the validity of the consensus threshold in ASCT applications but also highlight neglected conditions where monitoring post-thaw CD34s and clinical attributes are valuable.


  • Pregnancy-induced severe hypertriglyceridemia effectively treated with therapeutic plasmapheresis

    by Gustavo de Carvalho Duarte, Lauren Farnden, Ruth C.E. Hughes, Huan Chan


  • Open Access

    Targeting patient blood management's first pillar: A multicentric retrospective study on preoperative anemia

    by Gustavo de Carvalho Duarte, Glaciano Nogueira Ribeiro, Mariangela Moschen, Rodrigo Spessotto Morais Toledo, José Orlando Bordin, Dante Mario Langhi


  • Open Access

    Development and implementation of a COVID-19 convalescent plasma program in a middle-income economy

    by Gustavo de Carvalho Duarte, Vivian Simoni, Glaciano Nogueira Ribeiro, Ricardo Haddad, Mariangela Moschen, Rodrigo Spessotto Morais Toledo, Maria Angela Pignata Ottoboni, Alfredo Mendrone-Junior, Dante Mario Langhi


  • Open Access

    Serological and Molecular Study of the Duffy Blood Group among Malarial Endemic Region Residents in Brazil

    by Dante Langhi Júnior, Sérgio Albuquerque, Rui Serafim, Gustavo de Carvalho Duarte, Dimas Tadeu Covas, José O. Bordin

    The atypical chemokine receptor 1 (ACKR1) gene encodes the Duffy blood group antigens in two allelic forms: FY*A (FY*01) and FY*B (FY*02), which define the Fy(a+b-), Fy(a-b+), and Fy(a+b+) phenotypes. FY*BES (FY*02N.01) is a single T to C substitution at nucleotide -67 that prevents the FY*B from being expressed in red blood cells (RBCs).


  • Open Access

    Association of preoperative anemia and increased risk of blood transfusion and length of hospital stay in adults undergoing hip and knee arthroplasty: An observational study in a single tertiary center

    by Gustavo de Carvalho Duarte, Aguinaldo Pereira Catanoce, José Luiz Zabeu, Glaciano Nogueira Ribeiro, Mariangela Moschen, Nathália Aparecida Gonçalves de Oliveira, Dante Mario Langhi, José Francisco Comenalli Marques Júnior, Alfredo Mendrone‐Junior

    Background and aims: Anemia is a common feature in patients presenting for major elective surgery, and it is considered an independent risk factor associated with adverse outcomes. Although several studies suggest that preoperative anemia is associated with poor outcomes after elective orthopedic surgery, data are still scarce in middle‐ and low‐income countries where this problem may be even greater. The objective of this study was to evaluate the impact of preoperative anemia in clinical outcomes in patients submitted to hip and knee arthroplasty in a single tertiary hospital.Methods: Medical records of 234 adult patients submitted to knee and hip arthroplasty from January 2018 to July 2020 were retrospectively reviewed. Patient's demographics (ie, age and gender), pre‐ and postoperative hemoglobin level (Hb), allogeneic red blood cell (RBC) transfusion, intensive care admission, length of hospital stay, hospital readmissions, and mortality up to 30 days after the surgery were analyzed. Outcomes were evaluated according to preoperative anemia status based on World Health Organization (WHO) criteria.Results: Mean age was 70 years with a slight female predominance (57.6%). The prevalence of anemia was 30.7% (72/234) being more prevalent in female (33.3% vs 26.7%). Preoperative anemia was significantly associated with greater rate of blood transfusion (34.5% vs 5.6%; P = .001), prolonged length of hospital stay (6.48 days vs 3.36 days; P = .001), and higher rate of intensive care unit admission (47.2% and 29.6% P = .009). Preoperative anemia had no effect on 30‐day readmission and mortality for both males and females.Conclusions: Our retrospective study demonstrated that preoperative anemia is a common problem among orthopedic patients and is associated with increased transfusion risk and worse outcomes. Strategies to identify and treat anemic patients before elective surgery are critical to improving clinical outcomes.


  • Open Access

    Implementation of a patient blood management program based on a low-income country-adapted clinical decision support system

    by Gustavo de Carvalho Duarte, Francisco Guilherme Fujita Neto, José Francisco Comenalli Marques Júnior, Dante Mario Langhi